Efficacy of cabozantinib in advanced MiT family translocation renal cell carcinomas (TRCC).
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.6_suppl.274
Abstract: 274Background: MiT family translocation renal cell carcinomas (TRCC) represent a rare and aggressive subgroup of RCC harboring high expression of c-MET. While response rates of VEGF receptor-tyrosi... read more here.
Keywords: renal cell; mit family; family translocation; translocation renal ... See more keywords